ACELLYTRON THERAPEUTICS
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

ACELLYTRON THERAPEUTICS Trademark

Serial Number: 79406657 • Registration: 7797742

ACELLYTRON THERAPEUTICS is a trademark filed by Wuxi Biologics (Shanghai) Co., Ltd. on March 8, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Wuxi Biologics (Shanghai) Co., Ltd. (11 trademarks)

Building 2, No. 31 Yiwei Road,

Entity Type: 03

Trademark Details

Filing Date

March 8, 2024

Registration Date

May 20, 2025

Published for Opposition

April 1, 2025

Goods & Services

Research and development of new products for others; technological research in the field of chemical and biological medicaments; chemical analysis; biochemical research and analysis; research and development in the field of pharmaceutical preparations; medical research service; research and development of services in the field of antibodies; stem cell research services; medical research; medical and scientific research, namely, conducting clinical trials for others; biological research; computer programming in the field of medical aspects

Preparation of prescriptions by pharmacists; stem cell therapy services; medical clinic services; providing medical information; DNA screening for medical purposes; medical analysis services for the diagnosis of cancer; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; health care; medical assistance

Chemical-pharmaceutical preparations for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; biochemical medicines for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; vaccine preparations; influenza vaccine; chemotherapeutics; stem cells for medical purposes; medicines for human purposes for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; drugs for medical purposes, namely, medicines for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; drugs for treatment of cancer; medical preparation for treating diseases and disorders related to the immune system; biological agent, namely, biological preparations for treating cancer; pharmaceutical preparations for the prevention and treatment of cancer; living cells for medical use; medical cell inhibitor for inhibiting the growth of cancer cells; reagents for medical purposes; anticancer agent; diagnostic reagents for medical purposes; pharmaceutical preparations, namely, tumor suppressor; cells for medical use; dietetic infusions, sugar, foods, and beverages substances adapted for medical use; biological preparations for veterinary purposes for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer

Online advertising on a computer network; advertising services; publicity agents; dissemination of advertising and advertising matter in the nature of flyers, prospectuses, brochures, leaflets and samples; providing commercial information and advice for consumers in the choice of products and services; organization of exhibitions and trade fairs for commercial or advertising purposes; import-export agency services; marketing; sponsorship search; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 26, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 9, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 9, 2026 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 8, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 19, 2025 FICS
FINAL DISPOSITION PROCESSED
Dec 19, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 21, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 20, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 20, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 26, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 6, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 4, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 4, 2025 TROA
REFUSAL PROCESSED BY IB
Nov 17, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 30, 2024 RFCS
REFUSAL PROCESSED BY MPU
Oct 30, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 25, 2024 RFCR
NON-FINAL ACTION WRITTEN
Oct 24, 2024 CNRT
ASSIGNED TO EXAMINER
Oct 17, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 16, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 16, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 10, 2024 REPR